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StrokeMoyamoya disease is a condition of the cerebrovascular system that involves stenosis of the intracranial
internal carotid arteries as well as their proximal branches, often leading to stroke in affected patients. Here
we describe the case of a patient with headache and focal neurologic signs following exposure to a spicy
aroma, who initially had a negative vascular work-up and a preliminary diagnosis of a complex migraine
syndrome. She subsequently developed infarction of the left frontal lobe, and imaging studies revealed the
diagnosis of moyamoya disease. She was treated with an encephalodurosynangiosis procedure, with notable
improvement. This case highlights the importance of considering moyamoya disease in the differential
diagnosis of patients presenting with headaches with aura.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Moyamoya disease is a condition of the cerebrovascular system
that involves stenosis of the intracranial internal carotid arteries (ICA)
as well as their proximal branches, often leading to stroke in affected
patients [1]. These narrowed vessels in turn are thought to trigger the
growth of a network of collateral vessels from dilated perforating
leptomeningeal arteries, visible on angiography [2], leading to the
disease’s evocative name. In 1969, Suzuki and Takaku described
moyamoya as “a Japanese expression for something hazy just like a
puff of cigarette smoke drifting in the air [3].” The major imaging
features suggestive of moyamoya disease include stenoses in the
distal ICA and proximal middle cerebral (MCA) and anterior cerebral
arteries (ACA), in addition to increased vascularity in the basal ganglia
and thalamus from the collateral vessels [4]. Its predominant
histologic features include smooth muscle cell proliferation in intimal
layers of vessels, without atheromatous plaques [1]. Thromboembo-e substantial contributions to
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B.V. This is an open access article ulism or vasospasm may lead to ischemic presentations. The molecular
mechanisms include up-regulation of angiogenic factors and extra-
cellular matrix metalloproteinases [1]. A genome-wide association
study in 2012 identiﬁed RNF213, a gene encoding a specialized zinc-
ﬁnger protein, as a possible predictive DNA biomarker for severe
forms of moyamoya [5].
Common presentations include headaches, ischemic stroke,
transient ischemic attack, or intracerebral hemorrhage, and infre-
quently, seizures, choreiform movements or cognitive changes [1].
Moyamoyamay also be secondary to other causes, including radiation
therapy to the parasellar region, sickle cell disease, neuroﬁbromatosis
type 1, and trisomy 21 has also been reported in association with
hyperthyroidism, and renal artery stenosis [1].Case report
A 50-year-old female accountant with hypertension, diabetes
mellitus, and hyperlipidemia presented to an outside neurologist with
multiple transient episodes of speech disturbance and right-sided
weakness over ﬁve months. With each spell, the symptoms came on
gradually and were followed by a holocephalic headache 45 minutes
later. Two spells occurred shortly after the patient smelled a spicy
aroma from her husband’s cooking. She underwent work-up for
transient ischemic attack (TIA) at an outside facility, which included
head computed tomographic (CT) and magnetic resonance imaging
(MRI), cardiac rhythm monitoring, transthoracic and then trans-
esophageal echocardiography, as well as carotid ultrasound. These
studies were all normal. She was started on topiramate by hernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 2. Magnetic resonance angiogram demonstrating stenoses of the internal carotid
and middle cerebral arteries.
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prior history of migraine. She was given aspirin in addition to her
amlodipine, atorvastatin, lisinopril, metformin, and vilazodone. She
had no family history of stroke, did not use tobacco or illicit drugs, and
occasionally consumed alcohol.
Three days prior to being seen at this center, she then experienced
motor aphasia, weakness and numbness of the right face and right arm,
and headache not associated with external triggers. The event lasted less
than one hour. She then experienced two days of progressive difﬁculties
with speech expression, math, and typing. On examination, she was alert
and oriented to year but not place. She was cooperative, but had halting,
non-ﬂuent speech. She followed cross-body commands and repeated
phrases without difﬁculty. Her naming was intact for high- but not low-
frequency objects. Her visual ﬁelds and extraocular movements were
intact without nystagmus. She had slight ﬂattening of the right nasolabial
fold. Rapid ﬁnger tapping, pronator drift testing, and ﬁnger-nose-ﬁnger
testing were all normal.
A repeat MRI demonstrated interval infarction in the left frontal
lobe (Fig. 1). Aspirin was changed to aspirin plus extended-release
dipyridamole for secondary stroke prevention [7], and she partially
improved. Magnetic resonance angiography was performed, demon-
strating stenoses of the internal carotid and middle cerebral arteries,
worse on the left side, raising suspicion formoyamoya disease (Fig. 2).
The patient demonstrated enhancement on vessel wall imaging,
concerning for a cerebral angiitis. However, both erythrocyte
sedimentation rate and C-reactive protein level were only mildly
elevated. Anti-nuclear antibody titer was negative, with a negative
extractable nuclear antigen panel. Rheumatoid factor was negative.
IgM and IgG antibody titers for Lyme disease were negative. CSF
revealed normal cell counts, protein and glucose, and was negative for
angiotensin converting enzyme, varicella zoster, West Nile and
Epstein-Barr viruses, and syphilis. The possibility of an isolated
cerebral angiitis affecting small- and medium-sized vessels was
therefore unlikely [8]. Conventional catheter-based angiography
was then performed on the patient, which revealed the characteristic
stenosis of the ICAs intracranially and the classic “puff of smoke”Fig. 1. Fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging scan
demonstrating interval infarction in the left frontal lobe.appearance of the collateral vessels at the base of the brain in
moyamoya (Fig. 3).
Discussion
The key clinical feature is the presence of a stroke despite normal
cervical carotid imaging and cardiac monitoring, which is suggestive of
intracranial stenotic disease. The differential diagnosis is broad including
intracranial atheromatous disease, vasculitides (including CADASIL),
moyamoyadisease,ﬁbromusculardysplasia, and, less likely in this patient,
phakomatoses and infections (e.g. tuberculosis, syphilis). Normal inﬂam-
matory markers, autoimmune antibodies and cerebrospinal ﬂuid (CSF)
analysis may help eliminate these other causes, as described in her work-
upabove.Until ourpatientdevelopeda conﬁrmed infarction, thepresence
of focal neurologic signs in the setting of headache was suggestive of a
complex migraine syndrome, such as hemiplegic migraine. Indeed,
headache has been reported as a presenting symptom of moyamoya
disease and persists in up to 63% of patients following surgical
revascularization [9]. Case reports in the literature have described
migraines with aura in association with moyamoya disease – in one,
migraine was preceded by photopsia, followed by infarction of the left
occipital lobe [10]. It was postulated that borderline perfusion of the
occipital lobe contributed to the visual auras in that case [10]. Given the
distributionof the infarction inourpatient, a similarmechanismmayhave
been in effect.
Treatment options formoyamoya center around increasingbloodﬂow
to the affected areas and reducing ischemia. Antiplatelet therapy is
considered in asymptomatic patients or high-risk surgical candidates.
Calcium channel blockers may help headaches. However, few studies
report long-term beneﬁt frommedical management of moyamoya [1]. InFig. 3. Left internal carotid angiogram demonstrating classic “puff of smoke” collateral vessels.
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moyamoya patients later required surgical treatment [6].
Surgical revascularization is the deﬁnitive treatment method for
both children and adults. Indirect revascularization involves place-
ment of vascularized tissue in direct contact with the brain by creating
burr holes, encouraging neovascularization in the cerebral cortex [1].
This technique is usedwhen the recipient cortical artery is unavailable
for anastomosis, as in children with small vessels. Another indirect
revascularization technique, encephaloduroarteriosynangiosis, is usu-
ally the ﬁrst step in surgical management; here, a scalp artery is
sutured directly to a distal MCA branch. Another option is encepha-
lomyosynangiosis, in which a ﬂap of muscle is laid on the cortical
surface. Direct revascularization involves end-to-side anastomosis of
the superﬁcial temporal artery (STA) to middle cerebral artery (MCA).
Overall, outcomes for surgical revascularization treatments are good,
with no signiﬁcant difference between direct and indirect procedures.
The stroke risk is highest in the ﬁrst 30 days, after which 96% of
patients remain stroke-free after 5 years [1].
Conclusion
This case illustrates a remarkable presentation of moyamoya
disease, in which headache and focal neurologic signs associated with
a spicy aroma, coupled with normal carotid imaging and cardiac
monitoring despite vascular risk factors made intracranial athero-
sclerotic disease unlikely and initially led to the diagnosis of a
complex migraine syndrome.
In the case of our patient, she underwent an encephalodurosy-
nangiosis procedure, which she tolerated well. She has done very wellafter her surgery–her right side is completely improved, and her
aphasia has recoveredwith speech therapy. She has had no headaches
or new neurological symptoms, and she will continue to be followed
clinically. As of this writing, she has remained symptom-free for six
months after her surgery.
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